日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases

对BRAF V600E阳性黑色素瘤伴脑转移患者进行多模式管理和分子谱分析

Gritsch, David; Fadden, Riley M; Mahar, Maura K; Khandsekar, Melin J; Oh, Kevin S; Cahil, Daniel P 3rd; Dunn, Gavin P; Sullivan, Ryan J; Brastianos, Priscilla K

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial

阿贝西利治疗伴有体细胞NF2或CDK通路改变的脑膜瘤:Alliance A071401 II期试验

Brastianos, Priscilla K; Dooley, Katharine; Geyer, Susan; Gerstner, Elizabeth R; Kaufmann, Timothy J; Iafrate, A John; Martinez-Lage, Maria; Milhem, Mohammed; Welch, Mary Roberta; Kaley, Thomas J; Drappatz, Jan; Chan, Amy; Kumthekar, Priya; Matsuoka, Carlos Kamiya; Strowd, Roy E; Cohen, Adam L; Jaeckle, Kurt; Robell, Lindsay; Magge, Rajiv S; Nam, Joo Yeon; Blondin, Nicholas; Shaikh, Nawal; Rabinowitz, Ian; Thomas, Alissa A; Piccioni, David E; Brown, Paul; Kaluziak, Stefan; Codd, Elizabeth; Cahill, Daniel P; Santagata, Sandro; Barker, Frederick G 2nd; Galanis, Evanthia

Diverse organic molecules on Mars revealed by the first SAM TMAH experiment

首次SAM TMAH实验揭示火星上存在多种有机分子

Williams, Amy J; Eigenbrode, Jennifer L; Millan, Maëva; Williams, Ross H; Mcintosh, Ophélie M; Teinturier, Samuel; Roach, Janelle; Malespin, Charles; McAdam, Amy C; Mahaffy, Paul; Bryk, Alexander B; Buch, Arnaud; Boulesteix, David; Chou, Luoth; Dworkin, Jason P; Fox, Valerie; Franz, Heather B; Freissinet, Caroline; Glavin, Daniel P; House, Christopher H; Johnson, Sarah Stewart; Lewis, James M T; Mojarro, Angel; Navarro-Gonzalez, Rafael; Pozarycki, Chad; Steele, Andrew; Summons, Roger E; Szopa, Cyril; Thorpe, Michael T; Vasavada, Ashwin R

Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming

合作杂交小鼠的遗传多样性表明 FFAR3 是 ILC2 抗炎重编程的靶点

Mark Rusznak,Shinji Toki,Yajing Hao,Marc J C Todd,Liddy Malone,Julia F Goodhead,Catherine DuPuy,Weisong Zhou,Dominique Babin,Christian M Warren,Masako Abney,Matthew T Stier,Christopher M Thomas,Jing Li,Justin Jacobse,Andrew P Pahnke,Mark I Petrovic,Jacqueline-Yvonne Cephus,Shelby N Kuehnle,M Wade Calcutt,Allison E Norlander,Fang Yan,Jeremy A Goettel,Darla R Miller,Rachel M Lynch,Daniel P Cook,Dawn C Newcomb,Fei Zou,R Stokes Peebles Jr

Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension

Acoramidis治疗野生型和变异型转甲状腺素蛋白淀粉样变性心肌病的疗效:来自ATTRibute-CM及其开放标签扩展研究的结果

Alexander, Kevin M; Davis, Margot K; Akinboboye, Olakunle; Berk, John; Bhatt, Kunal; Cappelli, Francesco; Cuddy, Sarah A M; Fontana, Marianna; Garcia-Pavia, Pablo; Gillmore, Julian D; Griffin, Jan M; Grodin, Justin L; Judge, Daniel P; Khouri, Michel G; Lam, Kaitlyn; Masri, Ahmad; Maurer, Mathew S; Obici, Laura; Ruberg, Frederick L; Sarswat, Nitasha; Shah, Keyur; Soman, Prem; Stern, Lily; Wright, Richard; Xiong, Kuangnan; Cao, Xiaofan; Lystig, Ted; Tamby, Jean-François; Castaño, Adam; Katz, Leonid; Sinha, Uma; Fox, Jonathan C; Solomon, Scott D; Grogan, Martha

Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial

Acoramidis治疗转甲状腺素蛋白淀粉样变性心肌病的长期疗效:ATTRibute-CM随机临床试验的开放标签扩展研究

Soman, Prem; Cuddy, Sarah A M; Gillmore, Julian D; Sarswat, Nitasha; Judge, Daniel P; Cappelli, Francesco; Stern, Lily K; Wright, Richard; Akinboboye, Olakunle; Obici, Laura; Bhatt, Kunal; Xiong, Kuangnan; Castaño, Adam; Chen, Chris; Falvey, Heather; Pecoraro, Maria Lucia; Tamby, Jean-François; Sinha, Uma; Fox, Jonathan C; Shah, Keyur; Grodin, Justin L; Ambardekar, Amrut V; Alexander, Kevin M; Khouri, Michel G; Cheng, Richard K

Homo sapiens, industrialisation and the environmental mismatch hypothesis

智人、工业化与环境不匹配假说

Longman, Daniel P; Shaw, Colin N

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA Targeted Tubulysin Conjugate EC1169

在PSMA靶向Tubulysin缀合物EC1169的I期研究中,对CTC上PSMA表达进行相关性生物标志物分析和PSMA成像

Zaidi, Samir; Kuo, Phillip H; Paiva Prudente, Tiago; Lacuna, Kristine P; Babiker, Hani M; Aparicio, Renan; Schonhoft, Joseph D; Fernandez, Luisa; Messmann, Richard; Groaning, Michael; Tolcher, Anthony W; Gordon, Michael S; Yoo, Don C; Vaishampayan, Ulka; Picus, Joel; Petrylak, Daniel P; Sartor, Oliver; Morris, Michael J

Fifty Shades of Risk: Population Studies and the Genetic Architecture of Kidney Diseases

风险的五十种色调:人群研究与肾脏疾病的遗传结构

Sadeghi-Alavijeh, Omid; Chan, Melanie M Y; Stanescu, Horia; Gale, Daniel P; Bockenhauer, Detlef

Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort

瑞典代谢功能障碍相关脂肪肝疾病的患病率和危险因素:来自SCAPIS队列研究的启示

Nabi, Oumarou; Spaak, Jonas; Bergström, Göran; Engström, Gunnar; Johan Östgren, Carl; Malinovschi, Andrei; Kullberg, Joel; Blomberg, Anders; Jernberg, Tomas; Andersson, Daniel P; Hagström, Hannes